2021 research period for North America is officially open
March 24, 2021
Research team is now accepting firm submissions, due June 1
US
Mergers & Acquisitions
| Mergers & Acquisitions — Highly Recommended |
|---|
| Cooley |
| Goodwin Procter |
| Kirkland & Ellis |
| Latham & Watkins |
| Ropes & Gray |
| Skadden Arps Slate Meagher & Flom |
| Mergers & Acquisitions — Recommended |
|---|
| Arnold & Porter |
| Covington & Burling |
| Gibson Dunn & Crutcher |
| Hogan Lovells |
| Sidley Austin |
| WilmerHale |
Product Liability
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Beisner, John | Non-IP Litigation & Enforcement | Product Liability | Washington, D.C. |
| Bentivoglio, John | Non-IP Litigation & Enforcement | White-Collar/Govt. Investigations | Washington, D.C. |
| Bragg, Jennifer | Regulatory , Non-IP Litigation & Enforcement | FDA: Pharmaceutical, FDA: Medical Device, White-Collar/Govt. Investigations | Washington, D.C. |
| Brown, Allison | Non-IP Litigation & Enforcement | Product Liability | New York City |
| Gibson, Marie | Financial & Corporate | Licensing & Collaboration, Mergers & Acquisitions | New York City |
| Loucks, Michael | Non-IP Litigation & Enforcement | White-Collar/Govt. Investigations | Boston |
| Nemec, Douglas | Intellectual Property | Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | New York City |
| Robinson, Graham | Financial & Corporate | Mergers & Acquisitions | Boston |
| Schlossberg, Resa | Financial & Corporate | Licensing & Collaboration, Mergers & Acquisitions | New York City |
| Schnell, Paul | Financial & Corporate | Mergers & Acquisitions | New York City |
| Spaziano, Jennifer | Non-IP Litigation & Enforcement | White-Collar/Govt. Investigations | Washington, D.C. |
| Sunshine, Steven | Non-IP Litigation & Enforcement | Antitrust, White-Collar/Govt. Investigations | Washington, D.C. |
| Zisk, Matthew | New York City | ||
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Non-IP Litigation & Enforcement
Skadden Arps Slate Meagher & Flom
International law firm Skadden Arps Slate Meagher & Flom is noted by peers as having a “first-tier” life sciences mergers and acquisitions practice. The firm, which was recognized as the 2020 M&A Firm of the Year, is highly regarded for representing a number of high profile pharmaceutical and medical device companies, as well as emerging life sciences entities.
Graham Robinson is head of the firm’s Boston mergers and acquisitions group and is noted for representing both public and private companies in a number of transactions. Among his recent matters, Robinson, who one peer describes as a “great lawyer,” led the Skadden team advising Array BioPharma in its $11.4 billion acquisition by Pfizer, as well as Gilead Sciences in its $5.1 billion transaction with Galapagos NV.
In New York, the firm has perennial stars Marie Gibson and Paul Schnell. Gibson recently represented Foamix Pharmaceuticals in its merger with Menlo Therapeutics while Schnell was part of a team that advised Pfizer in two separate notes offerings which totaled $5.25 billion.